Riskpilot← Back to searchSign inGet full accessDr. Sinclair AB
ABActiveOrg 5592552813Fjätursvägen 23General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 26K
-87% vs 2023
EBITDA margin
7.7%
-99% vs 2023
Equity ratio
74.4%
Financial strength
Net profit 2024
SEK 1K
-99% vs 2023
| Revenue | SEK 26K | -87% |
| EBITDA | SEK 2K | -99% |
| Net profit | SEK 1K | -99% |
| Total assets | SEK 39K | -83% |
| Equity | SEK 29K | -80% |
| Employees | 0 | — |
Legal name
Dr. Sinclair AB
Org number
5592552813
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 maj 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten riktar sig till konsultarbete inom sjukvården. Undertecknad arbetar som läkare och kommer bedriva konsultverksamhet inom den privata vårdsektorn samt genomföra HLR-utbildningar.
Address
Fjätursvägen 23
Email
dr.sebastiansinclair@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 142 | 443 | 267 | 201 | 26 |
| Staff expenses | — | — | −5 | −5 | — |
| EBITDA | 121 | 415 | 200 | 141 | 2 |
| Depreciation & amort. | −0 | −0 | — | — | −0 |
| EBIT | 121 | 415 | 200 | 141 | 2 |
| Net financials | — | — | −0 | −1 | — |
| Profit before tax | 121 | 415 | 200 | 140 | 2 |
| Tax | −26 | −87 | −44 | −31 | −1 |
| Net profit | 95 | 328 | 156 | 109 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 192 | 567 | 429 | 233 | 39 |
| Equity | 120 | 353 | 239 | 148 | 29 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 72 | 214 | 190 | 85 | 10 |
| Total debt | 72 | 214 | 190 | 85 | 10 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
20202024
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20202024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20202024
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-05-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Sinclair AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Sebastian Sinclair | Board of Directors | 0 companies |
| Susanné Sinclair | Deputy Board Member | 0 companies |